keyword
https://read.qxmd.com/read/38643242/internet-delivered-therapy-for-alcohol-misuse-engagement-satisfaction-and-outcomes-when-patients-select-their-preference-for-therapist-or-self-guided-treatment
#1
JOURNAL ARTICLE
Ram P Sapkota, Tristen Lozinski, Andrew Wilhems, Marcie Nugent, Michael P Schaub, Matthew T Keough, Christopher Sundström, Heather D Hadjistavropoulos
BACKGROUND: Alcohol misuse is common and causes substantial harm. Internet-delivered cognitive behaviour therapy (ICBT) is effective in reducing alcohol misuse; however, the literature investigating how treatment outcomes are impacted by patients' preferences for therapist- versus self-guided ICBT for alcohol misuse is sparse. METHODS: In this preference trial, 74 eligible patients (who reported ≥ 14 drinks in the previous week and obtained scores suggesting hazardous or harmful drinking) chose between enrolling in either therapist- or self-guided ICBT for alcohol misuse...
April 20, 2024: Addiction Science & Clinical Practice
https://read.qxmd.com/read/38642595/subcutaneous-oxytocin-injection-reduces-heat-pain-a-randomized-controlled-trial
#2
JOURNAL ARTICLE
Benedetta Albinni, Marisa Zimmerman, Jacob Ross, Leyla Ozdoyuran, Vincent Alasha, Nathaniel M Schuster, Engy Said, Laura Case
Oxytocin 1 is a neuropeptide broadly implicated in social relationships and behavior. OT also exerts antinociceptive and pain-reducing effects in both humans and rodents. Recent research in rodents demonstrates that these effects can be peripheral and local. In human studies, intravenous OT has reduced visceral pain and subcutaneous injection of OT has reduced postsurgical pain. However, the local effects of subcutaneous OT on experimental pain have not been studied. We conducted a two-session crossover study during which healthy adults received a subcutaneous injection of synthetic OT (4mcg/2ml) or saline placebo (isotonic saline 2ml), in a randomized and double-blinded manner...
April 18, 2024: Journal of Pain
https://read.qxmd.com/read/38641236/sex-and-estrous-related-response-patterns-for-alcohol-depend-critically-on-the-level-of-compulsion-like-challenge
#3
JOURNAL ARTICLE
Thatiane De Oliveira Sergio, David Darevsky, Jacob Kellner, Vanessa de Paula Soares, Maryelle de Cassia Albino, Danielle Maulucci, Sarah Wean, Frederic W Hopf
Alcohol use disorder is a substantial social and economic burden. During the last years, the number of women with drinking problems has been increasing, and one main concern is that they are particularly more vulnerable to negative consequences of alcohol. However, little is known about female-specific response patterns for alcohol, and potential underlying differences in brain mechanisms, including for compulsion-like alcohol drinking (when intake persists despite adverse consequences). We used lickometry to assess behavioral microstructure in adult Wistar male and female rats (n = 28-30) during alcohol-only drinking or moderate- or higher-challenge alcohol compulsion (10 or 60 mg/L quinine in alcohol, respectively)...
April 17, 2024: Progress in Neuro-psychopharmacology & Biological Psychiatry
https://read.qxmd.com/read/38641026/neonatal-brain-inflammation-enhances-methamphetamine-induced-reinstated-behavioral-sensitization-in-adult-rats-analyzed-with-explainable-machine-learning
#4
JOURNAL ARTICLE
Kuo-Ching Wang, Norma B Ojeda, Haifeng Wang, Han-Sun Chiang, Michelle A Tucci, Jonathan W Lee, Han-Chi Wei, Asuka Kaizaki-Mitsumoto, Sachiko Tanaka, Nilesh Dankhara, Lu-Tai Tien, Lir-Wan Fan
Neonatal brain inflammation produced by intraperitoneal (i.p.) injection of lipopolysaccharide (LPS) results in long-lasting brain dopaminergic injury and motor disturbances in adult rats. The goal of the present work is to investigate the effect of neonatal systemic LPS exposure (1 or 2 mg/kg, i.p. injection in postnatal day 5, P5, male rats)-induced dopaminergic injury to examine methamphetamine (METH)-induced behavioral sensitization as an indicator of drug addiction. On P70, subjects underwent a treatment schedule of 5 once daily subcutaneous (s...
April 17, 2024: Neurochemistry International
https://read.qxmd.com/read/38638417/effects-of-systemic-pretreatment-with-the-naaladase-inhibitor-2-pmpa-on-oral-methamphetamine-reinforcement-in-c57bl-6j-mice
#5
JOURNAL ARTICLE
Elissa K Fultz, Andrea Y T Nei, Joyce C Chi, Jacqueline N Lichter, Karen K Szumlinski
INTRODUCTION: Repeated exposure to methamphetamine (MA) in laboratory rodents induces a sensitization of glutamate release within the corticoaccumbens pathway that drives both the rewarding and reinforcing properties of this highly addictive drug. Such findings argue the potential for pharmaceutical agents inhibiting glutamate release or its postsynaptic actions at glutamate receptors as treatment strategies for MA use disorder. One compound that may accomplish both of these pharmacological actions is the N -acetylated-alpha-linked-acidic dipeptidase (NAALADase) inhibitor 2-(phosphonomethyl)pentanedioic acid (2-PMPA)...
2024: Frontiers in Psychiatry
https://read.qxmd.com/read/38637154/circuit-wide-gene-network-analysis-reveals-sex-specific-roles-for-phosphodiesterase-1b-in-cocaine-addiction
#6
JOURNAL ARTICLE
Collin D Teague, Tamara Markovic, Xianxiao Zhou, Freddyson J Martinez-Rivera, Angelica Minier-Toribio, Alexander Zinsmaier, Nathalia V Pulido, Kyra H Schmidt, Kelsey E Lucerne, Arthur Godino, Yentl Y van der Zee, Aarthi Ramakrishnan, Rita Futamura, Caleb J Browne, Leanne M Holt, Yun Young Yim, Corrine H Azizian, Deena M Walker, Li Shen, Yan Dong, Bin Zhang, Eric J Nestler
Cocaine use disorder is a significant public health issue without an effective pharmacological treatment. Successful treatments are hindered in part by an incomplete understanding of the molecular mechanisms that underlie long-lasting maladaptive plasticity and addiction-like behaviors. Here, we leverage a large RNA-sequencing dataset to generate gene co-expression networks across 6 interconnected regions of the brain's reward circuitry from mice that underwent saline or cocaine self-administration. We identify phosphodiesterase 1b ( Pde1b ), a Ca2+ /calmodulin-dependent enzyme that increases cAMP and cGMP hydrolysis, as a central hub gene within a nucleus accumbens (NAc) gene module that was bioinformatically associated with addiction-like behavior...
April 18, 2024: Journal of Neuroscience
https://read.qxmd.com/read/38637101/deciphering-the-molecular-biology-of-inflammatory-breast-cancer-through-molecular-characterization-of-patient-samples-and-preclinical-models
#7
JOURNAL ARTICLE
Charlotte Rypens, Christophe Van Berckelaer, Fedor Berditchevski, Peter van Dam, Steven Van Laere
Inflammatory breast cancer is an aggressive subtype of breast cancer with dismal patient prognosis and a unique clinical presentation. In the past two decades, molecular profiling technologies have been used in order to gain insight into the molecular biology of IBC and to search for possible targets for treatment. Although a gene signature that accurately discriminates between IBC and nIBC patient samples and preclinical models was identified, the overall genomic and transcriptomic differences are small and ambiguous, mainly due to the limited sample sizes of the evaluated patient series and the failure to correct for confounding effects of the molecular subtypes...
2024: International Review of Cell and Molecular Biology
https://read.qxmd.com/read/38636807/a-pilot-randomized-controlled-trial-of-medication-adherence-therapy-psychosocial-leverage-using-a-significant-other-mat-plus-for-individuals-on-extended-release-naltrexone
#8
JOURNAL ARTICLE
Kevin Wenzel, Julia Thomas, Jennifer Carrano, Jennifer Stidham, Marc Fishman
BACKGROUND: Extended-release naltrexone (XR-NTX) is an important treatment option for individuals with opioid use disorder (OUD) and/or alcohol use disorder (AUD). However, problems with retention are a major barrier to its overall effectiveness, and interventions to improve adherence are underdeveloped. The purpose of this study was to pilot test the MAT-PLUS intervention, which combines assertive outreach and involvement of a treatment significant other (TSO) to improve adherence to XR-NTX...
April 15, 2024: J Subst Use Addict Treat
https://read.qxmd.com/read/38636082/comparison-of-opioid-use-disorder-patients-with-and-without-problematic-internet-use-in-terms-of-impulsivity-and-attention-deficit-hyperactivity-disorder
#9
JOURNAL ARTICLE
Neşe Burcu Bal, Bahar Yeşil Örnek
AIMS: This study seeks to investigate ADHD symptoms and impulsivity among individuals diagnosed with Opioid Use Disorder (OUD) who also exhibit symptoms of Problematic Internet Use (PIU). METHODS: The study involved the participation of 360 Opioid Use Disorder (OUD) patients enrolled at an Alcohol and Drug Addiction Treatment Center (ADATC) during the period from October to December 2022. Various assessment tools were administered, including Young's Internet Addiction Scale (YIAS), Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), Barratt Impulsiveness Scale (BIS), and Adult ADHD Self-Report Scale (ASRS)...
April 18, 2024: Revista Brasileira de Psiquiatria
https://read.qxmd.com/read/38635979/self-reported-disability-type-and-risk-of-alcohol-induced-death-a-longitudinal-study-using-nationally-representative-data
#10
JOURNAL ARTICLE
Jonathan Aram, Natalie Slopen, Candace Cosgrove, Amelia Arria, Hongjie Liu, Cher M Dallal
BACKGROUND: Disability is associated with alcohol misuse and drug overdose death, however, its association with alcohol-induced death remains understudied. OBJECTIVE: To quantify the risk of alcohol-induced death among adults with different types of disabilities in a nationally representative longitudinal sample of US adults. METHODS: Persons with disabilities were identified among participants ages 18 or older in the Mortality Disparities in American Communities (MDAC) study ( n  = 3,324,000)...
April 18, 2024: Substance Use & Misuse
https://read.qxmd.com/read/38635977/opioid-overdoses-and-take-home-naloxone-interventions-ethnographic-evidence-for-individual-level-barriers-to-treatment-of-opioid-use-disorders-in-rural-appalachia
#11
JOURNAL ARTICLE
Victor Garcia, Lisa McCann, Erick Lauber, Christian Vaccaro, Melissa Swauger, Daniel Alex Heckert
Introduction : Research indicates that take-home naloxone (THN) is saving lives across rural Appalachia, but whether it also results in treatment for opioid use disorders (OUDs) remains unclear. This study involves a detailed qualitative analysis of interviews with 16 individuals who had overdosed on opioids 61 times to understand why a THN intervention does not routinely lead to OUD treatment. Methods : This study builds upon a one-year (2018) qualitative study on community responses to opioid overdose fatalities in four adjacent rural counties in Western Pennsylvania...
April 18, 2024: Substance Use & Misuse
https://read.qxmd.com/read/38635339/family-based-therapy-for-internet-addiction-among-adolescents-and-young-adults-a%C3%A2-meta-analysis
#12
REVIEW
Hui Wang, Xiang Li, Grace Ka In Lok, Chunmei Meng, Yaheng Tan, Un Man Lee, Louisa Sok Man Lei, Natalia Chan
BACKGROUND AND AIMS: Internet addiction (IA) has been identified as a major public health problem that is more prominent in adolescents and young adults. Some researchers have indicated certain advantages of family-based therapy over other treatments in participants with IA, but no conclusive evaluation has been reported. The present meta-analysis aims to review the efficacy of family-based therapy on Internet addiction in adolescents and young adults. METHODS: Relevant articles published from 1996 to February 15th, 2024, were searched from 14 databases, including three Chinese databases...
April 17, 2024: Journal of Behavioral Addictions
https://read.qxmd.com/read/38635201/from-alcohol-detoxification-to-treatment-a-qualitative-interview-study-on-perceived-barriers-and-assessed-potential-of-mhealth-among-individuals-postdetoxification
#13
JOURNAL ARTICLE
Danilo Romero, Alexander Rozental, Per Carlbring, Magnus Johansson, Johan Franck, Anne H Berman, Philip Lindner
OBJECTIVE: Most individuals attending detoxification clinics do not pursue subsequent treatment. Earlier research has suggested that emerging technologies like mHealth interventions could address the postdetoxification treatment gap, yet it remains unclear whether patients themselves endorse such approaches. Our study aimed to qualitatively explore perceived treatment barriers and assessed potential of mHealth among individuals who have undergone alcohol detoxification. METHOD: We conducted a single-interview-per-participant qualitative study, sampling participants ( n = 23) that had visited the Stockholm substance use disorder emergency department for alcohol-related reasons, of whom n = 8 were purposively included due to having missed their scheduled follow-up outpatient appointment...
April 18, 2024: Psychology of Addictive Behaviors
https://read.qxmd.com/read/38631658/personality-traits-as-predictors-of-recovery-among-patients-with-substance-use-disorder
#14
JOURNAL ARTICLE
Elise Constance Fodstad, Aleksander Hagen Erga, Ståle Pallesen, Anastasia Ushakova, Eilin Kristine Erevik
INTRODUCTION: Substance use disorder (SUD) is often considered a chronic illness in which prolonged recovery, in terms of abstinence, is uncommon. Personality has been found to predict recovery, but not much is known about its long-term predictive ability as the majority of previous studies have had short follow-up periods (≥ one year). The current longitudinal cohort study therefore investigated whether personality traits predict short- (STR) as well as long-term recovery (LTR) in SUD patients...
April 15, 2024: J Subst Use Addict Treat
https://read.qxmd.com/read/38631657/an-exploration-of-organizational-climate-in-community-based-opiate-prescribing-services-a-mixed-methods-study
#15
JOURNAL ARTICLE
Peter Kelly, Adam Searby, Johnny Goodwin
INTRODUCTION: Assessing the internal dynamics of organizations has been shown to provide information that can help planners and policymakers improve service delivery. A good organizational climate, which in this study incorporates mission clarity, team cohesion, staff autonomy, communication, levels of stress, and openness to change has been shown to be of particular importance. Still, there is a dearth of evidence in this area, and while relationships between organizational factors have been identified, little is known about the mechanisms that might underpin these relationships, and there is little understanding of how to address deficits once they are identified...
April 15, 2024: J Subst Use Addict Treat
https://read.qxmd.com/read/38630316/teneurin-c-terminal-associated-peptide-tcap-1-attenuates-the-development-and-expression-of-naloxone-precipitated-morphine-withdrawal-in-male-swiss-webster-mice
#16
JOURNAL ARTICLE
Lauren E Mueller, Roseanne S Wexler, David A Lovejoy, Robert B Stein, Andrew M Slee
RATIONALE: Corticotropin-releasing factor (CRF), the apical stress-inducing hormone, exacerbates stress and addictive behaviors. TCAP-1 is a peptide that directly inhibits both CRF-mediated stress and addiction-related behaviors; however, the direct action of TCAP-1 on morphine withdrawal-associated behaviors has not previously been examined. OBJECTIVE: To determine whether TCAP-1 administration attenuates behavioral and physiological consequences of morphine withdrawal in mice...
April 17, 2024: Psychopharmacology
https://read.qxmd.com/read/38630190/neuromarkers-in-addiction-definitions-development-strategies-and-recent-advances
#17
REVIEW
Nicholas R Harp, Tor D Wager, Hedy Kober
Substance use disorders (SUDs) are the most costly and prevalent psychiatric conditions. Recent calls emphasize a need for biomarkers-measurable, stable indicators of normal and abnormal processes and response to treatment or environmental agents-and, in particular, brain-based neuromarkers that will advance understanding of the neurobiological basis of SUDs and clinical practice. To develop neuromarkers, researchers must be grounded in evidence that a putative marker (i) is sensitive and specific to the psychological phenomenon of interest, (ii) constitutes a predictive model, and (iii) generalizes to novel observations (e...
April 17, 2024: Journal of Neural Transmission
https://read.qxmd.com/read/38628972/non-invasive-suppression-of-the-human-nucleus-accumbens-nac-with-transcranial-focused-ultrasound-tfus-modulates-the-reward-network-a-pilot-study
#18
JOURNAL ARTICLE
Xiaolong Peng, Dillon J Connolly, Falon Sutton, John Robinson, Brenna Baker-Vogel, Edward B Short, Bashar W Badran
BACKGROUND: The nucleus accumbens (NAc) is a key node of the brain reward circuit driving reward-related behavior. Dysregulation of NAc has been demonstrated to contribute to pathological markers of addiction in substance use disorder (SUD) making it a potential therapeutic target for brain stimulation. Transcranial focused ultrasound (tFUS) is an emerging non-invasive brain stimulation approach that can modulate deep brain regions with a high spatial resolution. However, there is currently no evidence showing how the brain activity of NAc and brain functional connectivity within the reward network neuromodulated by tFUS on the NAc...
2024: Frontiers in Human Neuroscience
https://read.qxmd.com/read/38627958/mapping-structural-covariance-networks-of-emotional-withdrawal-symptoms-in-males-with-methamphetamine-use-disorder-during-abstinence
#19
JOURNAL ARTICLE
Xian Mo, Ping Jiang, Jiayu Sun, Lu Lu, Lei Li, Xiaoqi Huang, Jiajun Xu, Jing Li, Junran Zhang, Qiyong Gong
Individuals with methamphetamine use disorder (MUD) often experience anxiety and depressive symptoms during abstinence, which can worsen the likelihood of relapse. Thus, it is essential to understand the neuro-mechanism behind methamphetamine use and its associated emotional withdrawal symptoms in order to develop effective clinical strategies. This study aimed to evaluate associations between emotional withdrawal symptoms and structural covariance networks (SCNs) based on cortical thickness (CTh) across the brain...
April 2024: Addiction Biology
https://read.qxmd.com/read/38627909/from-taboo-to-treatment-the-emergence-of-psychedelics-in-the-management-of-pain-and-opioid-use-disorder
#20
REVIEW
Jeremy Weleff, Julio C Nunes, Gabriel P A Costa, Mehmet Sofuoglu, R Ross MacLean, Joao P De Aquino
The rise of psychedelics in contemporary medicine has sparked interest in their potential therapeutic applications. While traditionally associated with countercultural movements and recreational use, recent research has shed light on the potential benefits of psychedelics in various mental health conditions. In this review, we explore the possible role of psychedelics in the management of chronic pain and opioid use disorder (OUD), 2 critical areas in need of innovative treatment options. Pain control remains a significant clinical challenge, particularly for individuals with OUD and those who receive long-term opioid therapy who develop marked tolerance to opioid-induced analgesia...
April 16, 2024: British Journal of Clinical Pharmacology
keyword
keyword
73565
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.